This paper evaluates the social value of investing in vaccine research, development, and manufacturing capacity for pandemic preparedness and response. Rapid vaccination during pandemics can significantly reduce mortality, economic losses, and societal disruptions. However, vaccine manufacturers often lack sufficient incentives for speed and capacity expansion. Strategic policies by governments and international organizations could enhance these incentives and improve equitable vaccine distribution.

More on this topic

BFI Working Paper·Feb 4, 2025

Local GDP Estimates Around the World

Esteban Rossi-Hansberg and Jialing Zhang
Topics: COVID-19, Economic Mobility & Poverty
BFI Working Paper·Jan 22, 2025

Network Rewiring and Spatial Targeting: Optimal Disease Mitigation in Multilayer Social Networks

Ozan Candogan, Michael D. König, Kieran Marray, and Frank W. Takes
Topics: Health care
BFI Working Paper·Jan 21, 2025

Disease, Disparities, and Development: Evidence from Chagas Disease Control in Brazil

Jon Denton-Schneider and Eduardo Montero
Topics: Development Economics, Health care